The first people treated with epigenetic reprogramming

For the first time, older people have been treated with a new form of therapy that aims to reprogram their cells. This is done through a technique called epigenetic reprogramming, in which the genetic material in cells is temporarily modified to make them function more youthful. This treatment uses a special viral vector, the so-called adeno-associated virus (AAV), which can alter the genetic material in cells.

This special step was made possible by some courageous individuals within the community who want to stay healthy for longer. They took advantage of gene innovations that have been used in the medical tourism industry for years. Organizations such as Triple Helix Science and BioViva have gained experience with the use of AAV therapies, making this treatment more accessible to individuals. Formal scientific publications on the effects are still lacking, but those involved hope to be able to share more data in the future.

The AAV technique used is relatively safe and easy to produce, which makes it different from many other forms of gene therapy. This makes it easier to apply such treatments on a larger scale. However, it is still important to be cautious and thoroughly investigate the effects, as these new medical methods are still in full development.

This development offers hope for a better approach to combating aging. By rejuvenating cells, we may be able to age with better health and fewer age-related symptoms. This type of innovation can therefore contribute to healthy and vibrant aging.

Source: Reason